So far, over 300 FAD PS1 mutations have been reported, which leads to the manifestation of AD-associated clinical and pathological features such as amyloid-β (Aβ) plaques, tau neurofibrillary tangles, synaptic abnormalities, and neuronal loss [2–7]. The gene discussed is PSEN1; the disease is Alzheimer disease.